1 - 25 of 28 results for author:"Akahira J." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. Shibahara Y., Miki Y., Onodera Y., Hata S., Chan M.S., Yiu C.C., Loo T.Y., Nakamura Y., Akahira J., Ishida T. et al. J. Pathol. 227:357-366(2012) · Mapped (9) |
| Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor betacx in human prostate carcinoma. Nagasaki S., Nakamura Y., Maekawa T., Akahira J., Miki Y., Suzuki T., Ishidoya S., Arai Y., Sasano H. Neoplasma 59:224-232(2012) · Mapped (2) |
| Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Suzuki S., Takagi K., Miki Y., Onodera Y., Akahira J., Ebata A., Ishida T., Watanabe M., Sasano H., Suzuki T. Cancer Sci. 103:136-143(2012) · Mapped (5) |
| Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production. Uruno A., Matsuda K., Noguchi N., Yoshikawa T., Kudo M., Satoh F., Rainey W.E., Hui X.G., Akahira J., Nakamura Y. et al. J. Mol. Endocrinol. 46:37-49(2011) · Mapped (13) |
| Runx2 in human breast carcinoma: its potential roles in cancer progression. Onodera Y., Miki Y., Suzuki T., Takagi K., Akahira J., Sakyu T., Watanabe M., Inoue S., Ishida T., Ohuchi N. et al. Cancer Sci. 101:2670-2675(2010) · Mapped (3) |
| Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Oka K., Suzuki T., Onodera Y., Miki Y., Takagi K., Nagasaki S., Akahira J., Ishida T., Watanabe M., Hirakawa H. et al. Int. J. Cancer 128:1770-1782(2011) · Mapped (1) |
| Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer. Yue X., Akahira J., Utsunomiya H., Miki Y., Takahashi N., Niikura H., Ito K., Sasano H., Okamura K., Yaegashi N. Pathol. Int. 60:400-406(2010) · Mapped (8) |
| Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects. Hata S., Miki Y., Fujishima F., Sato R., Okaue A., Abe K., Ishida K., Akahira J., Unno M., Sasano H. Life Sci. 86:393-401(2010) · Mapped (10) |
| Transcriptional regulation of 17beta-hydroxysteroid dehydrogenase type 12 by SREBP-1. Nagasaki S., Miki Y., Akahira J., Suzuki T., Sasano H. Mol. Cell. Endocrinol. 307:163-168(2009) · Mapped (14) |
| Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. Miki Y., Suzuki T., Nagasaki S., Hata S., Akahira J., Sasano H. J. Steroid Biochem. Mol. Biol. 113:281-289(2009) · Mapped (56) |
| 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis. Nagasaki S., Suzuki T., Miki Y., Akahira J., Kitada K., Ishida T., Handa H., Ohuchi N., Sasano H. Cancer Res. 69:1392-1399(2009) · Mapped (5) |
| Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Nagasaki S., Suzuki T., Miki Y., Akahira J., Shibata H., Ishida T., Ohuchi N., Sasano H. Cancer Sci. 100:639-645(2009) · Mapped (3) |
| Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. Suzuki F., Akahira J., Miura I., Suzuki T., Ito K., Hayashi S., Sasano H., Yaegashi N. Cancer Sci. 99:2365-2372(2008) · Mapped (56) |
| Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Akahira J., Suzuki F., Suzuki T., Miura I., Kamogawa N., Miki Y., Ito K., Yaegashi N., Sasano H. Pathol. Int. 57:725-733(2007) · Mapped (5) |
| Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer. Ota K., Ito K., Akahira J., Sato N., Onogawa T., Moriya T., Unno M., Abe T., Niikura H., Takano T. et al. Int. J. Gynecol. Pathol. 26:334-340(2007) · UniProtKB (1) · Mapped (2) |
| Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Suzuki T., Urano T., Miki Y., Moriya T., Akahira J., Ishida T., Horie K., Inoue S., Sasano H. Cancer Sci. 98:644-651(2007) · Mapped (10) |
| Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. Sakuma M., Akahira J., Ito K., Niikura H., Moriya T., Okamura K., Sasano H., Yaegashi N. Cancer Sci. 98:380-386(2007) · Mapped (2) |
| Expression of organic cation transporter SLC22A16 in human endometria. Sato N., Ito K., Onogawa T., Akahira J., Unno M., Abe T., Niikura H., Yaegashi N. Int. J. Gynecol. Pathol. 26:53-60(2007) · UniProtKB (1) · Mapped (2) |
| 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Suzuki T., Miki Y., Moriya T., Akahira J., Ishida T., Hirakawa H., Yamaguchi Y., Hayashi S., Sasano H. Int. J. Cancer 120:285-291(2007) · Mapped (12) |
| Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. Saito S., Ito K., Nagase S., Suzuki T., Akahira J., Okamura K., Yaegashi N., Sasano H. Cancer Sci. 97:1308-1314(2006) · Mapped (10) |
| 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer. Ito K., Suzuki T., Akahira J., Sakuma M., Saitou S., Okamoto S., Niikura H., Okamura K., Yaegashi N., Sasano H. et al. Clin. Cancer Res. 11:7384-7391(2005) · Mapped (1) |
| Orphan nuclear receptor DAX-1 in human endometrium and its disorders. Saito S., Ito K., Suzuki T., Utsunomiya H., Akahira J., Sugihashi Y., Niikura H., Okamura K., Yaegashi N., Sasano H. Cancer Sci. 96:645-652(2005) · Mapped (3) |
| Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Akahira J.I., Aoki M., Suzuki T., Moriya T., Niikura H., Ito K., Inoue S., Okamura K., Sasano H., Yaegashi N. Br. J. Cancer 90:2197-2202(2004) · Mapped (5) |
| Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Akahira J., Sugihashi Y., Suzuki T., Ito K., Niikura H., Moriya T., Nitta M., Okamura H., Inoue S., Sasano H. et al. Clin. Cancer Res. 10:2687-2693(2004) · Mapped (2) |
| Progesterone production and actions in the human central nervous system and neurogenic tumors. Inoue T., Akahira J., Suzuki T., Darnel A.D., Kaneko C., Takahashi K., Hatori M., Shirane R., Kumabe T., Kurokawa Y. et al. J. Clin. Endocrinol. Metab. 87:5325-5331(2002) · Mapped (10) |